Carolyn Britten
Overview
Explore the profile of Carolyn Britten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Giordano A, Liu Y, Armeson K, Park Y, Ridinger M, Erlander M, et al.
PLoS One
. 2019 Nov;
14(11):e0224420.
PMID: 31751384
Within triple negative breast cancer, several molecular subtypes have been identified, underlying the heterogeneity of such an aggressive disease. The basal-like subtype is characterized by mutations in the TP53 gene,...
2.
Sessa C, Shapiro G, Bhalla K, Britten C, Jacks K, Mita M, et al.
Clin Cancer Res
. 2013 Jun;
19(13):3671-80.
PMID: 23757357
Purpose: A phase I study was conducted with the primary objective of determining the maximum tolerated dose (MTD) of AUY922 in patients with advanced solid tumors. Secondary objectives included characterization...
3.
Gelmon K, Belanger K, Soulieres D, Britten C, Chia S, Charpentier D, et al.
Invest New Drugs
. 2005 Sep;
23(5):445-53.
PMID: 16133796
Background: T900607 is a novel tubulin active agent which disrupts microtubule polymerization by a unique mechanism of action. This phase I trial was conducted to determine the maximum tolerated dose,...
4.
Lu D, Yu N, Raman S, Lassman C, Tong M, Britten C, et al.
Hepatology
. 2005 Apr;
41(5):1130-7.
PMID: 15841454
Orthotopic liver transplantation (OLT) can be a definitive treatment for patients with hepatocellular carcinoma (HCC). Prolonged waiting times for cadaveric livers, however, may lead to dropout from the waiting list...